5060
S. M. Rele et al. / Tetrahedron Letters 48 (2007) 5055–5060
11. Hayashida, O.; Mizuki, K.; Akagi, K.; Matsuo, A.;
Supplementary data
Kanamori, T.; Nakai, T.; Sando, S.; Aoyama, Y. J. Am.
Chem. Soc. 2003, 125, 594–601.
12. Benito, J. M.; Gomez-Garcia, M.; Mellet, C.; Baussanne,
I.; Defaye, J.; Fernandez, J. M. J. Am. Chem. Soc. 2004,
66, 7786–7795.
13. (a) Kobayashi, K.; Tsuchida, A.; Usui, T.; Akaike, T.
Macromolecules 1997, 30, 2016–2020; (b) Choi, S. K.;
Mammen, N.; Whitesides, G. M. J. Am. Chem. Soc. 1997,
119, 4103–4111; (c) Zanini, D.; Roy, R. J. Org. Chem.
1998, 63, 3486–3491.
Experimental procedures and spectral data are provided
for compounds 8b, 12–16, and 18–22. Supplementary
data associated with this article can be found, in the
References and notes
1. (a) Lapcik, L., Jr.; Lapcik, L.; Smedt, S.; Demeester, J.;
Chabrecek, P. Chem. Rev. 1998, 98, 663–2684; (b) Under-
hill, C. B. In The Biology of Hyaluronan; Foundation, C.,
Ed.; John Wiley: Chichester, UK, 1989; pp 87–106; (c)
Laurent, T. C. The Chemistry Biology and Medical
Applications of Hyaluronan and its Derivatives; Portland:
London, 1998.
2. Toole, B. P. J. Clin. Invest. 2000, 106, 335–336.
3. (a) Entwistle, J.; Hall, C. I.; Turley, E. A. J. Cell Biochem.
1996, 61, 569–577; (b) Evanko, S. P.; Wight, T. N. J.
Histochem. Cytochem. 1999, 47, 1331–1342.
14. (a) Ashton, P. R.; Boyd, S. E.; Brown, C. L.; Jayaraman,
N.; Nepogodiev, S. A.; Stoddart, J. F. Chem. Eur. J. 1996,
2, 1115–1128; (b) Kensinger, R.; Yowler, B.; Benesi, A.;
Schengrund, C.-L. Bioconjugate Chem. 2004, 15, 349–
358.
15. (a) Iyer, S. S.; Rele, S. M.; Baskaran, S.; Chaikof, E. L.
Tetrahedron 2003, 59, 631–638; (b) Rele, S. M.; Iyer, S. S.;
Baskaran, S.; Chaikof, E. L. J. Org. Chem. 2004, 69, 9159–
9170; (c) Rele, S. M.; Cui, W.; Hou, S.; Barr-Zarse, G.;
Tatton, D.; Gnanou, Y.; Esko, J.; Chaikof, E. L. J. Am.
Chem. Soc. 2005, 127, 10132–10133; (d) Iyer, S. S.; Rele, S.
M.; Nolan, S.; Grasa, G.; Chaikof, E. L. Chem. Commun.
2003, 1518–1519; (e) Rele, S. M.; Iyer, S. S.; Chaikof, E. L.
Tetrahedron Lett. 2003, 44, 89–91.
16. (a) Quiocho, F. A. Annu. Rev. Biochem. 1986, 55, 287–315;
(b) Weis, W. I.; Drickamer, K. Annu. Rev. Biochem. 1996,
65, 441–473; (c) Miyauchi, H.; Yuri, M.; Tanaka, M.;
Kawamura, N.; Hayashi, M. Bioorg. Med. Chem. Lett.
1997, 7, 989; (d) Davis, B. G. J. Chem. Soc., Perkin Trans.
1 1999, 3215–3237.
4. Travis, J. A.; Hughes, M. G.; Wong, J. M.; Wagner, W.
D.; Geary, R. L. Circ. Res. 2001, 88, 77–83.
5. (a) McKee, C.; Penno, M.; Cowman, M.; Burdick, M.;
Strieter, R.; Bao, C.; Noble, P. J. Clin. Invest. 1996, 98,
2403–2413; (b) McKee, C.; Lowenstein, C.; Horton, M.;
Wu, J.; Bao, C.; Chin, B.; Choi, A.; Noble, P. J. Biol.
Chem. 1997, 272, 8013–8018; (c) Hodge-Dufour, J.; Noble,
P.; Horton, M. R.; Bao, C.; Wysoka, M.; Burdick, M. D.;
Strieter, R. M.; Trinchieri, G.; Pure’, E. J. Immunol. 1997,
15, 2492–2500.
17. Poretz, R. D.; Goldstein, I. J. Biochem. Pharmacol. 1971,
20, 2727.
18. Vasella, A.; Witzig, C.; Chiara, J.-L.; Martin-Lomas, M.
Helv. Chim. Acta 1991, 74, 2073–2077.
6. McKee, C. M.; Penno, M. B.; Cowman, M.; Burdick, M.
D.; Strieter, R. M.; Bao, C.; Noble, P. W. J. Clin. Invest.
1996, 98, 2403–2413.
7. (a) Lees, V. C.; Fan, T. P.; West, D. C. Lab. Invest. 1995,
73, 259–266; (b) West, D.; Hampson, I.; Arnold, F.;
Kumar, S. Science 1985, 228, 1324–1326.
19. Jacquinet, J. C. Carbohydr. Res. 1990, 199, 153–181.
20. Buskas, T.; Soderbegh, E.; Konradsson, P.; Fraser-Reid,
B. J. Org. Chem. 2000, 65, 958–963.
8. Zeng, C.; Toole, B. P.; Kinney, S. D.; Kuo, J. W.;
Stamenkovic, I. Int. J. Cancer 1996, 77, 396–401.
9. (a) Lundquist, J. J.; Toone, E. J. Chem. Rev. 2002, 102,
555–578; (b) Mammen, M.; Choi, S.; Whitesides, G. M.
Angew. Chem., Int. Ed. 1998, 37, 2754–2794.
10. (a) Baigude, H.; Katsuraya, K.; Okuyama, K.; Tokunaga,
S.; Uryu, T. Macromolecules 2003, 36, 7100–7106; (b)
Veprek, P.; Jezek, J. J. Pept. Sci. 1999, 5, 5–23.
21. Greene, T. W.; Wuts, P. G. Protecting Groups in Organic
Synthesis, 3rd ed.; Wiley: New York, 1999, Chapter 7, p
494.
22. A small percentage (<5%) of mono and tri functionalized
glycoligands could also be observed in the MALDI-TOF
spectrum of the crude mixture, however no attempts were
made to purify the compounds.